Guidelines are urgently needed on the judicious use of cholinergic drugs. Cholinesterase inhibitors remain pivotal to the treatment of Alzheimer disease (AD), but no specific guidelines are ...

Cholinesterase inhibitors prevent the breakdown of a chemical messenger (acetylcholine) important for learning and memory (Figure 1). The levels of this chemical are low in the brains of people ...

Geriatrics and Aging. 2009;12(4):202-207. © 2009 1453987 Ontario, Ltd. Cite this: Practical Approach to the Use of Cholinesterase Inhibitors in Patients With Early ...

LONDON, GREATER LONDON, UNITED KINGDOM, March 26, 2025 /EINPresswire / -- The year 2024 saw the cholinesterase ChE inhibitors market size at a whopping $3.92 billion, and this impressive figure is ...

It sees advancements with new drug classes like cholinesterase inhibitors. The global Alzheimer's disease therapeutics market size is projected to expand by $5.41b from 2024-2028 with an estimated ...